The Aperio Blog
Aperio Receives Medidata Rave Coder Accreditation
October 25, 2018
Aperio is committed to offering our pharmaceutical, biotechnology and device clients expertise in state-of-the-art technology that optimizes the clinical research process and gets drugs to market faster for patients in need.
A Medidata Partner since 2017, Aperio announced earlier this year that they have been expanding their use of the Medidata Clinical Cloud® platform to help support all aspects of clinical research from study planning to study close. In keeping with the expansion, Aperio is now pleased to announce that they have received full accreditation to provide medical coding services using Medidata’s leading cloud-based medical coding application, Medidata Rave Coder.
Aperio has already received full accreditation to provide electronic data capture services for clinical trials using Medidata Rave EDC. Aperio is working on accreditation in several of Medidata’s other best-in-class clinical trial cloud technologies.
Transparency with our clients is one of Aperio’s most important differentiators. By providing a single source of truth, the Medidata platform allows Aperio to live out this core value with our clients every day.
About Aperio Clinical Outcomes
Aperio Clinical Outcomes offers essential services for today’s complex, data-intensive oncology and rare disease clinical trials: rock-solid fit-for-purpose database development and management, unmatched analytics expertise, and powerful holistic tools that deliver the most coherent and actionable views of essential data. Just as important, in an industry flooded with promises, we make only one: We tell the truth, no matter what.
